Your Location:
Home >
Browse articles >
Mechanism of Modified Erzhiwan Combined with Epimedium for Atherosclerosis Based on Network Pharmacology
Mechanism of Modified Erzhiwan Combined with Epimedium for Atherosclerosis Based on Network Pharmacology
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 3, Pages: 175-182(2020)
DOI: 10.13422/j.cnki.syfjx.20200336
Scan QR Code
Full Text(HTML)
Figs( 5 ) Tabs( 3 )
References
Publication Info
Metrics
63
Views
55
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Explore Potential Molecular Mechanism of Gegen Qinliantang in Intervention of Atherosclerosis Based on Network Pharmacology and Molecular Docking
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Pharmacological Effect of Glycyrrizae Radix et Rhizoma Compatibility and Its Mechanism
Mechanism of Polygonati Rhizoma on Treating Osteoporosis Based on Network Pharmacology and Preliminary Verification
Mechanism of Gegen Qinliantang against Vulnerable Plaque of Atherosclerosis: Based on Macrophage Pyroptosis Mediated by NF-κB/NLRP3/Caspase-1 Pathway
Related Author
Yi ZHENG
He GUO
Xi LUO
Yan-jie WANG
Dan-yu ZHAO
Xiao-fan FENG
Bao-kun LI
Jing-yu WANG
Related Institution
Liaoning University of Traditional Chinese Medicine,Shneyang
School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.
ASEAN Joint Laboratory for International Cooperation in Traditional Medicine Research,Guangxi University of Chinese Medicine


